If you tuned in to NPR this morning, you probably heard Brenda Wilson’s story on the latest efforts to develop a pill or gel to protect women against HIV infection.
The piece highlights the frustration that more concrete progress has not been made. It has inspired a lively discussion from listeners posting comments on NPR’s website. Click here to listen and join the conversation. And post a comment here too!
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Jacqueline Hellen and Lisa Parker of MEASURE Evaluation While programs in low- and middle-income countries seek to support children […]
When provinces in Canada lifted restrictions pegging eligibility for treatment for hepatitis C with direct-acting antivirals to the stage of...